Cardiac resynchronization therapy is associated with reductions in left atrial volume and inappropriate implantable cardioverter-defibrillator therapy in MADIT-CRT.
PubWeight™: 0.75‹?›
Published in Heart Rhythm on February 04, 2014
Authors
Tyler Slyngstad1, Anne-Christine Huth Ruwald2, Valentina Kutyifa1, Scott McNitt1, Bronislava Polonsky1, Scott D Solomon3, Elyse Foster4, Ilan Goldenberg5, Paul J Wang6, Helmut Klein1, Wojciech Zareba1, Arthur J Moss7
Author Affiliations
1: Heart Research Follow-up Program of the of the Department of Medicine, University of Rochester Medical Center, Rochester, New York.
2: Heart Research Follow-up Program of the of the Department of Medicine, University of Rochester Medical Center, Rochester, New York; Gentofte University Hospital, Department of Cardiology, Copenhagen, Denmark.
3: Brigham and Women's Hospital, Boston, Massachusetts.
4: University of California San Francisco Hospital, San Francisco, California.
5: Sheba Medical Center and Tel Aviv University, Tel Aviv, Israel.
6: Cardiology Division, Stanford University School of Medicine, Palo Alto, California.
7: Heart Research Follow-up Program of the of the Department of Medicine, University of Rochester Medical Center, Rochester, New York. Electronic address: heartajm@heart.rochester.edu.
Articles by these authors ⇆